Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers

Summary

This is a randomized, double-blind, single dose, dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of NCTX (PEGylated Liposomal Iodixanol Injection) administered intravenously to healthy volunteers. In addition, computed tomography (CT) scans will be acquired to measure radiographic density in regions of interest (ROI) at times from 3-5 hours and up to 72 hours following NCTX administration.

Timeline

Start

2014-03

Primary completion

2014-10

Completion

2014-10

Drugs

Indications

No indication recorded.